You can buy or sell Chembio and other stocks, options, ETFs, and crypto commission-free!
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. Its products include human and veterinary diagnostics. Read More The company was founded in 1985 and is headquartered in Medford, NY.
Medford, New York
52 Week High
52 Week Low
Simply Wall StMar 18
Do Insiders Own Lots Of Shares In Chembio Diagnostics, Inc. (NASDAQ:CEMI)?
A look at the shareholders of Chembio Diagnostics, Inc. (NASDAQ:CEMI) can tell us which group is most powerful. Institutions often own shares in more established companies, while it’s not unusual to see insiders own a fair bit of smaller companies. Warren Buffett said that he likes ‘a business with enduring competitive advantages that is run by able and owner-oriented people’. So it’s nice to see some insider ownership, because it may suggest that management is owner-oriented. With a market capitalization ...
Guru FocusMar 18
Chembio Diagnostics Inc (CEMI) Files 10-K for the Fiscal Year Ended on December 31, 2018
Chembio Diagnostics Inc (NASDAQ:CEMI) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Chembio Diagnostics Inc develops, manufactures, and commercializes point of care diagnostic tests that detect infectious diseases.
Seeking AlphaMar 7
Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q4 2018 Results - Earnings Call Transcript
Call Start: 16:30 January 1, 0000 5:03 PM ET Chembio Diagnostics, Inc. (NASDAQ:CEMI) Q4 2018 Earnings Conference Call March 7, 2019 04:30 PM ET Company Participants Philip Taylor - IR John Sperzel - President, CEO Neil Goldman - CFO Conference Call Participants Per Ostlund - Craig-Hallum Capital Group Kyle Bauser - Dougherty & Company Bruce Jackson - The Benchmark Company Operator Good day, ladies and gentlemen, and welcome to your Chembio Diagnostics Fourth Quarter and Full-Year 2018 Earnings ...
-$0.17 per share
-$0.21 per share